Viyash Scientific512529Deal closure update
Viyash Scientific arm Alivira completes 100% acquisition of BioForLife Italia S.r.l.; base consideration EUR 15.0 million
- Stake Acquired
- 100% of the share capital
- Base Purchase Consideration
- EUR 15.0 million payable on closing
- Deferred Consideration
- EUR 1.976 million payable as deferred consideration subject to adjustments
- Completion Date
- October 1, 2026
- SPA Date
- July 21, 2026
Viyash Scientific arm Alivira completes 100% acquisition of BioForLife Italia S.r.l.; base consideration EUR 15.0 million.
Net financial position reference date reference date
Sale and Purchase Agreement executed
Closing / completion date
More numbers
- Base purchase considerationEUR 15.0 million
- Deferred balance purchase considerationEUR 1.976 million
- Share capital acquired in BioForLife Italia S.r.l.100%
Source: BSE · 1 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.